COHEN JACOB D. (CEO) received a stock award from MANGOCEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/30/2025ACC: 0001493152-25-016352
DirectorOfficer10% Owner· CEO
Since Mar 2023
+200K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
200K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
New position
4/10/2025
0.00→200K
Total
Net shares
+200K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/10/2025 | A · Award | +200K | — | — | New position | 0.00 | 200K |
| Total | +200K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned605K
Total
605K direct605K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 605K | Direct |
| Total | 605K | 605K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported